What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards...
Expert equity analysis, earnings previews, and data-driven market research.
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards...
Conagra Brands (CAG) is scheduled to report its third-quarter results on Thursday before the market opens. The packaged...
Tiffany & Co. (TIF), a leading manufacturer and retailer of designer jewelry, is scheduled to report the fourth-quarter...
The market is quite upbeat about the third-quarter financial performance of Herman Miller (MLHR), which is slated to...
After the IPO in April 2018, shares of the subscription services provider Zuora (NYSE: ZUO) has been volatile...
Lifestyle products designer Guess? Inc. (GES) is scheduled to report its earnings for the fourth quarter on Wednesday...
Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) rose 13% on February 25 when the US patent office extended...
Renewables product company Amyris (AMRS) is set to report its fourth quarter and full-year 2018 results on Monday,...
Tilray (TLRY), which has been trailing other cannabis stocks since the start of this year, will be put...
Chipmaking giant Broadcom Inc. (AVGO) is touted to post its first-quarter 2019 earnings on March 14. According to...
Brazilian aerospace company Embraer (ERJ) Thursday reported a net loss for the fourth quarter of 2018, compared to...
Fresh after the recently completed merger with Hortonworks, Cloudera (NYSE: CLDR) announced its fourth-quarter 2019 results on March...